ATHIRA PHARMA INC
(NASDAQ: ATHA)

Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018. The company was founded by Leen Kawas, John Wright, Lewis Rumpler, and Joseph Harding in March 2011 and is headquartered in Bothell, WA.

2.730

+0.170 (+6.64%)
Range - - -   (-%)
Open -
Previous Close 2.560
Bid Price 2.830
Bid Volume 9
Ask Price 2.840
Ask Volume 9
Volume 578,095
Value -
Remark
Delayed prices. Updated at 29 Mar 2024 03:59.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis